PA Medical News about Menopause Hormone Replacement Therapy

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

New Ovarian Cancer Test Guides Surgical Decisions

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hormone therapy following menopause
The Clinical Advisor, 11/06/09

Sherman C – The risk/benefit ratio is highest in younger women who begin hormone therapy (HT) not long after menopause. HT is approved for two indications: relief of vasomotor symptoms and prevention of osteoporosis. Research suggests that HT may be beneficial for preventing diabetes, improving mood, or avoiding urinary tract problems. Using HT long beyond menopause carries increased risks, which, for some women, may be outweighed by the benefits.

<< Previous
Misclassifying nonexempt employees as exempt can cost you

Next >>
FDA Approves Revisions to Prescribing Information for Diabetes...